2019 Annual Meeting of the European Association for the Study of the Liver*

April 10-14, 2019; Vienna, Austria
Get the latest viral hepatitis and NASH data with rapid Capsule Summaries and downloadable slidesets covering key studies from Vienna.
Nancy Reau, MD
Zobair Younossi Headshot
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Stefan Zeuzem, MD

Highlights

Listen as expert faculty discusses the clinical impact of the most important NAFLD/NASH data from the Vienna meeting.

Zobair Younossi Headshot Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD Released: May 2, 2019

Listen to expert commentary on the clinical impact of data from the Vienna meeting regarding treatment of viral hepatitis and progress toward HCV elimination.

Stefan Zeuzem, MD Released: May 10, 2019

Expert faculty members summarize key studies on hepatitis C treatment and elimination, hepatitis B treatment, NASH/NAFLD clinical impact, and NASH treatment studies from this important annual conference.

Nancy Reau, MD Zobair Younossi Headshot Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD Stefan Zeuzem, MD Released: April 30, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by:
AbbVie
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue